Flow-Injection Chemiluminometric Determination of Pioglitazone HCl by Its Sensitizing Effect on the Cerium-Sulfite Reaction

被引:16
作者
Al-Arfai, Nawal A. [1 ]
Al-Abdulkareem, Eman A. [1 ]
Aly, Fatma A. [1 ]
机构
[1] King Saud Univ, Dept Chem, Coll Sci, Women Student Med Studies & Sci Sect, Riyadh 11495, Saudi Arabia
关键词
PERFORMANCE LIQUID-CHROMATOGRAPHY; THIN-LAYER-CHROMATOGRAPHY; HUMAN PLASMA; CHEMILUMINESCENCE DETERMINATION; PHARMACEUTICAL FORMULATIONS; HUMAN SERUM; PHASE; HPLC; HYDROCHLORIDE; ROSIGLITAZONE;
D O I
10.2116/analsci.25.401
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A flow injection chemiluminescent (FI-CL) method was developed for the determination of pioglitazone HCl. It is based on the sensitizing effect of the drug on the oxidation reaction of sulfite with cerium(IV). The different experimental parameters affecting the chemiluminescence intensity, such as concentration of reagents and some physical parameters of the manifold, were carefully studied and incorporated into the procedure. The method permits the determination of 0.05-3.0 mu g mi(-1) of pioglitazone HCl with correlation coefficient r = 0.9999. The lower limit of detection (LOD) is 0.01 mu g ml(-1) (SIN = 2) and the lower limit of quantitation (LOQ) is 0.05 mu g ml(-1). The proposed method was compared with other reported methods and was found to be equally accurate and precise. It was successfully applied to the determination of the drug in pharmaceutical preparations and in biological fluids.
引用
收藏
页码:401 / 406
页数:6
相关论文
共 32 条
[1]  
Alonso MCS, 2001, ANAL CHIM ACTA, V437, P225
[2]   Flow-injection chemiluminometric analysis of some benzamides by their sensitizing effect on the cerium-sulphite reaction [J].
Aly, FA ;
Alarfaj, NA ;
Alwarthan, AA .
TALANTA, 2001, 54 (04) :715-725
[3]  
Caulcutt R.Boddy R., 1983, Statistics for analytical chemists, VFirst
[4]   A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus [J].
Chilcott, J ;
Tappenden, P ;
Jones, ML ;
Wight, JP .
CLINICAL THERAPEUTICS, 2001, 23 (11) :1792-1823
[5]  
DAI JD, 2001, YAOWU FENXI ZAZHI, V21, P36
[6]   Reversed-phase thin-layer chromatography of three new oral antidiabetics and densitometric determination of pioglitazone [J].
Gumieniczek, A ;
Hopkala, H ;
Berecka, A .
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2004, 27 (13) :2057-2070
[7]   Normal- and reversed-phase thin-layer chromatography of seven oral antidiabetic agents [J].
Gumieniczek, A ;
Hopkala, H ;
Berecka, A ;
Kowalczuk, D .
JPC-JOURNAL OF PLANAR CHROMATOGRAPHY-MODERN TLC, 2003, 16 (04) :271-275
[8]   Detection of anti-diabetics in equine plasma and urine by liquid chromatography-tandem mass spectrometry [J].
Ho, ENM ;
Yiu, KCH ;
Wan, TSM ;
Stewart, BD ;
Watkins, KL .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 811 (01) :65-73
[9]   Generic, highly selective and robust capillary electrophoresis method for separation of a racemic mixture of glitazone compounds [J].
Jamali, B ;
Theill, GC ;
Sorensen, LL .
JOURNAL OF CHROMATOGRAPHY A, 2004, 1049 (1-2) :183-187
[10]   Investigation of racemisation of the enantiomers of glitazone drug compounds at different pH using chiral HPLC and chiral CE [J].
Jamali, Babak ;
Bjornsdottir, Inga ;
Nordfang, Ole ;
Hansen, Steen Honore .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 46 (01) :82-87